Filing Details
- Accession Number:
- 0001410442-23-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 10:22:58
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-15 10:22:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1410442 | Vivek Jain | 951 Calle Amanecer San Clemente CA 92673 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-14 | 6,712 | $58.79 | 30,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 6,712 | $185.73 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 3,637 | $58.79 | 27,314 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 3,637 | $186.50 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 2,781 | $58.79 | 26,458 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 2,781 | $187.43 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 8,163 | $58.79 | 31,840 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 8,163 | $188.52 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 785 | $58.79 | 24,462 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 785 | $189.32 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 1,699 | $58.79 | 25,376 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 1,699 | $190.48 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 1,601 | $58.79 | 25,278 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 1,601 | $192.06 | 23,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 2,104 | $58.79 | 25,781 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 2,418 | $58.79 | 28,199 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 2,418 | $194.02 | 25,781 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-14 | 100 | $58.79 | 25,881 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-14 | 100 | $194.73 | 25,781 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-06-14 | 2,104 | $193.30 | 23,677 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 6,712 | $0.00 | 6,712 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 3,637 | $0.00 | 3,637 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 2,781 | $0.00 | 2,781 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 8,163 | $0.00 | 8,163 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 785 | $0.00 | 785 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 1,699 | $0.00 | 1,699 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 1,601 | $0.00 | 1,601 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 2,104 | $0.00 | 2,104 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 2,418 | $0.00 | 2,418 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-06-14 | 100 | $0.00 | 100 | $58.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 199,654 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 196,017 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 193,236 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 185,073 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 184,288 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 182,589 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 180,988 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 178,884 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 176,466 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
| 176,366 | 2018-02-13 | 2024-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 60,000 | Indirect | by Trust |
Footnotes
- The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.05 to $187.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.05 to $188.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.06 to $189.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.16 to $191.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.44 to $192.385, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $194.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- All shares sold were sold at the exact price disclosed.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.52 to $193.515, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
